These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

897 related items for PubMed ID: 17637743

  • 1. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F, Strand DW, Rowley DR.
    Oncogene; 2008 Jan 17; 27(4):450-9. PubMed ID: 17637743
    [Abstract] [Full Text] [Related]

  • 2. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ, Ressler SJ, Larsen M, Tuxhorn JA, Yang F, Dang TD, Rowley DR.
    Cancer Res; 2003 Sep 15; 63(18):5859-65. PubMed ID: 14522910
    [Abstract] [Full Text] [Related]

  • 3. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y, Kyprianou N.
    Cancer Res; 1999 Mar 15; 59(6):1366-71. PubMed ID: 10096572
    [Abstract] [Full Text] [Related]

  • 4. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
    Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR.
    Cancer Res; 2002 Jun 01; 62(11):3298-307. PubMed ID: 12036948
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW, Douville K, Benbow U, Brinckerhoff CE, Memoli VA, Arrick BA.
    Oncogene; 2002 Jan 03; 21(1):108-18. PubMed ID: 11791181
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
    Kim IY, Zelner DJ, Lee C.
    Exp Cell Res; 1998 May 25; 241(1):151-60. PubMed ID: 9633523
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
    Tang B, de Castro K, Barnes HE, Parks WT, Stewart L, Böttinger EP, Danielpour D, Wakefield LM.
    Cancer Res; 1999 Oct 01; 59(19):4834-42. PubMed ID: 10519393
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
    Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, Kato M, Lee C.
    Cancer Res; 1996 Jan 01; 56(1):44-8. PubMed ID: 8548772
    [Abstract] [Full Text] [Related]

  • 18. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S, Lee J, Revelo M, Wang X, Lu S, Dong Z.
    Clin Cancer Res; 2007 Oct 01; 13(19):5692-702. PubMed ID: 17908958
    [Abstract] [Full Text] [Related]

  • 19. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Bierie B, Stover DG, Abel TW, Chytil A, Gorska AE, Aakre M, Forrester E, Yang L, Wagner KU, Moses HL.
    Cancer Res; 2008 Mar 15; 68(6):1809-19. PubMed ID: 18339861
    [Abstract] [Full Text] [Related]

  • 20. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
    Ko Y, Banerji SS, Liu Y, Li W, Liang J, Soule HD, Pauley RJ, Willson JK, Zborowska E, Brattain MG.
    J Cell Physiol; 1998 Aug 15; 176(2):424-34. PubMed ID: 9648930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.